47 reports

  • Ramsay Health Care Limited: Key Employees
  • Southern Cross Healthcare Group: key facts

Table ##: New Zealand healthcare providers sector value: $ billion, 2015-## Figure ##: New Zealand healthcare providers sector value: $ billion, 2015-## ##.

  • Healthcare
  • Australasia
  • New Zealand
  • Market Size
  • Ramsay Health Care Limited
  • HEALTHCARE PARAMETERS, NEW ZEALAND
  • HEALTHCARE EXPENDITURE, NEW ZEALAND

nvpm=##|##||||##|||##|##|##|##|##|##|##|##|## [Accessed on January ##, 2018] BIBLIOGRAPHY Overview of Healthcare Sector Market Access, Reimbursement Landscape, New Zealand Out-of-Pocket Health Expenditure Market Access, Reimbursement Land

  • Healthcare
  • Medical Device
  • Medical Equipment
  • Pharmaceutical
  • New Zealand

It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies.

  • Healthcare
  • Australasia
  • New Zealand
  • Demand
  • Market Size
  • ICT MARKET OPPORTUNITY IN THE HEALTH CARE SECTOR BY CATEGORY, USD MILLION, 2016 - 2019
  • ICT MARKET OPPORTUNITY IN THE HEALTH CARE SECTOR BY CATEGORY, USD MILLION, 2016 - 2019

Within the body of this report Kable present the market size and forecast spending trends for the sector which covers: TABLE ##: CATEGORY DEFINITIONS Domain Category Definition cards are now almost always built into PCs as a standard.

  • Healthcare
  • ICT
  • New Zealand
  • Market Segment
  • Market Size
  • Major Companies
  • Major Players

High capital intensity is more than $##. ## of capital to $## of labour; medium is $##. ## to $##. ## of capital to $## of labour; low is less than $##. ## of capital for every $## of labour.

  • Dentistry
  • Healthcare
  • New Zealand
  • Demand
  • Forecast

Understanding of the market by getting the veritable big picture including an overview of the healthcare system.

  • Healthcare
  • New Zealand
  • Demand
  • Market Size
  • Supply

(Philips Healthcare) ##. ##. ##.

  • Diagnostic Imaging
  • Healthcare
  • Australasia
  • New Zealand

GlobalData Sopharma AD, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 Deal Type Acquisition Divestiture - Company No. of Deals ## ## Deal Value (US$ million) ##. ## NA Sopharma AD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 Sopharma

  • Healthcare
  • New Zealand
  • Company
  • M&A
  • Sopharma Group
  • Capital Intensity
  • PLAYER PERFORMANCE

High capital intensity is more than $##. ## of capital to $## of labour; medium is $##. ## to $##. ## of capital to $## of labour; low is less than $##. ## of capital for every $## of labour.

  • Health Services
  • Healthcare
  • New Zealand
  • Forecast
  • Capital Intensity
  • PLAYER PERFORMANCE

High capital intensity is more than $##. ## of capital to $## of labour; medium is $##. ## to $##. ## of capital to $## of labour; low is less than $##. ## of capital for every $## of labour.

  • Eyewear
  • Healthcare
  • Ophthalmology
  • New Zealand
  • Demand
  • Overview of Employee Benefits in New Zealand
  • 6.5 MEDICAL BENEFITS

As of April ##, 2018, the law is voluntary, but it is will be mandatory from April ##, 2019.

  • Healthcare
  • Pension
  • Australasia
  • New Zealand
  • Economy
  • OTHER COMPANIES
  • Major Players

High capital intensity is more than $##. ## of capital to $## of labour; medium is $##. ## to $##. ## of capital to $## of labour; low is less than $##. ## of capital for every $## of labour.

  • Diagnostic Imaging
  • Healthcare
  • Pathology
  • New Zealand
  • Demand
  • Number of births
  • Operating Conditions

High capital intensity is more than $##. ## of capital to $## of labour; medium is $##. ## to $##. ## of capital to $## of labour; low is less than $##. ## of capital for every $## of labour.

  • Healthcare
  • Hospital
  • New Zealand
  • Demand
  • Forecast
  • Feb 21, 2018: EBOS delivers record first-half earnings
  • OTHER LOCATIONS & SUBSIDIARIES

In October 2016, EBOS completed the merger of its Chemmart business with Terry White Group to create one of Australia' s largest retail pharmacy networks.

  • Healthcare
  • Pharmaceutical
  • New Zealand
  • Company Financials
  • Ebos Group Ltd

The company' s deal volume decreased from two pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • New Zealand
  • Company
  • Company Financials
  • Living Cell Technologies Limited
  • Metlifecare Ltd, Pharmaceuticals & Healthcare, Deal Details
  • Metlifecare Ltd, Key Competitors

Metlifecare Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 www. metlifecare. co. nz ##. ## NA Web Address Revenue (US$ million) Number of Employees GlobalData Metlifecare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 Metlifecare Ltd, Pharmaceuticals &am

  • Health Services
  • Healthcare
  • New Zealand
  • M&A
  • Metlifecare Limited

High capital intensity is more than $##. ## of capital to $## of labour; medium is $##. ## to $##. ## of capital to $## of labour; low is less than $##. ## of capital for every $## of labour.

  • Health Services
  • Healthcare
  • New Zealand
  • Demand
  • Forecast
  • BASIS OF COMPETITION
  • INTERNATIONAL TRADE

High capital intensity is more than $##. ## of capital to $## of labour; medium is $##. ## to $##. ## of capital to $## of labour; low is less than $##. ## of capital for every $## of labour.

  • Health Services
  • Healthcare
  • New Zealand
  • Demand

New Zealand Medical Imaging Services Market - Opportunity Analysis and Industry Forecast, 2017-2023 CHAPTER ##: INTRODUCTION ##. ##.

  • Diagnostic Imaging
  • Healthcare
  • Australasia
  • New Zealand
  • Forecast

Ryman Healthcare Ltd.

  • Healthcare
  • Nursing Home
  • Australasia
  • New Zealand
  • Market Competition
  • OPERATING LANDSCAPE
  • Industry revenue

High capital intensity is more than $##. ## of capital to $## of labour; medium is $##. ## to $##. ## of capital to $## of labour; low is less than $##. ## of capital for every $## of labour.

  • Health Insurance
  • Healthcare
  • Private Health Insurance
  • New Zealand
  • Forecast
  • Abano Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deal Details
  • Abano Healthcare Group Ltd, Other Locations

GlobalData Deal Type Equity Offerings Acquisition Divestiture - Company No. of Deals ## ## ## Deal Value (US$ million) NA ##. ## NA Abano Healthcare Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 Abano Healthcare Group Ltd, Pha

  • Healthcare
  • Australasia
  • New Zealand
  • M&A
  • Abano Healthcare Group Limited
  • Capital Intensity
  • substantial entry barrier.

Oceania Healthcare Holdings making up the balance.

  • Elderly Care
  • Health Services
  • Healthcare
  • Nursing Home
  • New Zealand
  • INDUSTRY PERFORMANCE
  • ABOUT THIS INDUSTRY

Real household disposable income health care providers.

  • Health Services
  • Healthcare
  • New Zealand
  • Demand

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Australasia
  • New Zealand

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Australasia
  • New Zealand

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Australasia
  • New Zealand

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Australasia
  • New Zealand
  • New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • New Zealand Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

GlobalData New Zealand Pharmaceuticals Ltd' s, deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Pharmaceutical
  • New Zealand
  • Deals & Alliance

GlobalData is one of the world' s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally.

  • Analgesic
  • Healthcare
  • Pharmaceutical
  • Therapy
  • New Zealand